RBC says proposed US rules on China biotech investment have minimal impact
RBC Capital Markets analysts say the US Treasury’s proposed rules on biotechnology investment in China would have minimal impact.
Related stories
OPC Energy Financing Includes $625 Million Term Loan
The financing also includes a $125 million letter of credit and a $75 million revolver.
L impact | EQUITY | Oct 29, 2026, 04:44 PM UTC
Nasdaq Falls as Alphabet Faces Record Loss Amid AI Spending Woes
U.S. stocks are lower, with the Dow down 0.35%. Alphabet is set for a record loss amid concerns over AI spending.
M impact | EQUITY | Oct 29, 2026, 04:44 PM UTC
High Quality Food reports Q3 2026 revenue of €4.6 million
M impact | EQUITY | Oct 29, 2026, 04:44 PM UTC
High Quality Food Q3 Revenue Rises 4% to EUR 4.67 Million
M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC
CPV Secures $825 Million Financing for Two U.S. Power Plants
OPC Energy's U.S. subsidiary CPV secured $825 million in financing for the Shore and Maryland power plants. The structure consolidates existing project-level debt under a single fa
M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC
X-FAB Expects Q4 Revenue of $205-215 Million
X-FAB expects fourth-quarter revenue within a range of $205-215 million.
M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC